Bitget App
Trade smarter
Buy cryptoMarketsTradeFuturesEarnSquareMore

DMAC stock price forecast

How will DMAC stock perform in 2026 and 2030?

This page primarily displays the projected price range for DMAC stock over the next 12 months, as well as trading recommendations for the next three months. This data is based on the historical performance of DMAC, the development trends of DiaMedica Therapeutics Inc., and a summary of analysis reports from major international investment banks and Wall Street research institutions, along with price analyses and forecasts from well-known analysts on platforms such as TradingView and Reddit. Together, these sources form a comprehensive market outlook for DMAC. The forecast includes potential high, median, and low price scenarios to help users understand possible future price movements across different time horizons.

This page combines DiaMedica Therapeutics Inc.'s financial performance and industry trends to provide short-term price predictions for DMAC stock over the next one to two years, as well as long-term price predictions extending to 2030.

The data is updated regularly as new market information becomes available. The information on this page is for reference only and does not constitute investment advice.

1-year DMAC stock price forecast

Price target:
14.42 USD
+69.05%
Based on 1-year price forecasts from 27 analysts, the highest estimate is 19.19 USD, while the lowest estimate is 8.35 USD.

Analyst rating for DMAC

Based on ratings from 21 analysts over the past three months, the overall consensus is Hold.

Strong buy
0
Buy
12
Hold
2
Sell
2
Strong sell
5

FAQ

How has DMAC's EPS performed recently?

DMAC's EPS is projected to reach -- USD next quarter. Explore more DiaMedica Therapeutics Inc. financial data and stay up to date on the company's latest developments on the DMAC stock details page.

What is the revenue forecast for DMAC next quarter?

DiaMedica Therapeutics Inc.'s revenue is projected to reach -- USD in the next quarter. You can view DiaMedica Therapeutics Inc.'s revenue and earnings on the DMAC stock details page.

What is the price target for DMAC?

Based on analyst estimates, the most likely target price for DMAC over the next 12 months is 14.42 USD, with a projected high of 19.19 USD and a projected low of 8.35 USD. To track whether this target is reached within the next year, you can view the DMAC stock price chart on the DMAC stock details page to check the current DMAC stock price, or follow the latest developments related to DMAC on the DMAC Stock News page.

What is the analyst rating for DMAC?

We collected ratings from 21 analysts who have evaluated DMAC stock over the past three months. Most analysts maintain a Hold outlook, and after aggregating all opinions, the overall consensus rating is Hold. Please note that this information does not constitute trading advice. You should still conduct your own research.

What is the projected price of DMAC stock in 2030?

Based on price forecasts and analyses of DiaMedica Therapeutics Inc. from Wall Street analysts and major investment banks, DMAC is projected to trade between 17.06 USD and 85.30 USD in 2030.

DMAC stock chart

DMAC stock details

DMAC stock price change

On the last trading day, DMAC stock closed at 8.53 USD, with a price change of -1.16% for the day.

Trade stock futures

About Bitget

The world's first Universal Exchange (UEX), enabling users to trade not only cryptocurrencies, but also stocks, ETFs, forex, gold, and real-world assets (RWA).
Learn more
NASDAQ/
DMAC stock price forecast